世界のデスモプレシン市場 – 業界動向と2030年までの予測

デスモプレシン市場分析と規模

デスモプレシンは、夜間多尿、尿崩症、血友病 A、ヴィレブランド病、尿毒症出血など、さまざまな病状の治療に使用されています。尿崩症の発症率の増加と子供の夜尿症の急増により、デスモプレシン酢酸塩の市場が世界的に活況を呈しています。デスモプレシン酢酸塩の製造業者は、夜尿症の予防策や尿崩症の治療に関する啓発プログラムなど、数多くのプロモーション活動とともに、地域的な製品展開を強化すると予想されています。

データブリッジ市場調査は、2023年から2030年の予測期間におけるデスモプレシン市場の成長率を分析しています。デスモプレシン市場の予想CAGRは、上記の予測期間において約5.8%になる傾向があります。市場は2022年に10億5,563万米ドルと評価され、2030年までに16億5,728万米ドルまで成長すると予想されています。市場価値、成長率、市場セグメント、地理的範囲、市場プレーヤー、市場シナリオなどの市場洞察に加えて、データブリッジ市場調査チームがまとめた市場レポートには、詳細な専門家分析、患者疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

デスモプレシン市場の範囲とセグメンテーション

Market Definition

Desmopressin is a type of vasopressin and is widely used to replace a low level of vasopressin. The desmopressin medication aids in controlling the rising urge of urination and dehydration. It has also been used to control night-time bedwetting in children. Furthermore, in conditions such as diabetes insipidus, wherein the body produces an abnormally large amount of urine, desmopressin medicines have been used widely.

Desmopressin Market Dynamics

Drivers

• Growing Prevalence of Diabetes

The number of people suffering from diabetes rise from 108 million in 1980 to 422 million in 2014. Prevalence has increased rapidly in low and middle-income countries compared to high-income countries. Between 2000 and 2019, there was a 3% increase in diabetes mortality rates by age. In 2019, diabetes and kidney disease due to diabetes caused an estimated 2 million deaths. Numerous studies have shown that zinc improves glucose levels in people suffering from diabetes. This leads to the market growth.

• Increased Awareness About the Diseased Conditions

The developing research associated with the market increases the expansion rate during the forecast period. The more adoption of clinical drugs for this diseased condition will bring much favourable outcomes. Furthermore, the treatment involves both counseling sessions and drugs. Therefore, the market tends to grow at a fast pace considering both the options.

Opportunities

• Increasing Investments by Several market Players

There have been rising investments by multiple market players that are helping boost the market's growth. For instance, in September 2017, Amring Pharmaceuticals announced its plans to invest in desmopressin acetate to meet its commitment of providing high-quality generic medicines and excellent customer service at a reasonable price.

Restraints/Challenges

• Side-Effects of Antipsychotic Drugs

Desmopressin can show major complications. Heavy dosage of this drug can cause flushing, nausea, transient headache, and mild abdominal cramps. This hampers the market growth.

This desmopressin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the desmopressin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Desmopressin Market Scope

The desmopressin market is segmented on the basis of form, applications, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Form

• Injectable Solution
• Nasal Spray
• Tablet

Applications

• Paediatric Use
• Geriatric Use

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Desmopressin Market Regional Analysis/Insights

The desmopressin market is analyzed and market size insights and trends are provided by form, applications, distribution channel and end-user as referenced above.

The major countries covered in the desmopressin market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific will expect the highest growth for the desmopressin market throughout the forecasted period due to increased new research and developments on the desmopressin market.

North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Desmopressin Market Share Analysis

デスモプレシン市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。提供されている上記のデータ ポイントは、デスモプレシン市場に関連する会社の焦点にのみ関連しています。

デスモプレシン市場で活動している主要企業は次のとおりです。

• ファイザー社（米国）
• テバ製薬工業株式会社（イスラエル）
• NorthStar Rx LLC (米国)
• サン・ファーマシューティカル・インダストリーズ（インド）
• アヴェニットAG（中国）
• フェリングBV（スイス）
• アムリング・ファーマシューティカルズ社（米国）
• アポテックス株式会社（カナダ）
• Glenmark Pharmaceuticals Ltd (インド)
• マイランNV（米国）

SKU-57349